Seth Robey is the Director of Quantitative Pharmacology and Pharmacometrics at Merck, where they lead efforts in developing modeling and simulation strategies for drug development. They previously served as a Principal Scientist, Senior Scientist, and Associate Principal Scientist at Merck, specializing in immuno-oncology and the pharmacokinetics of Keytruda. Prior to this, Robey was an Associate Consultant at Pharmagellan, contributing to research on biotech financial modeling. They hold a Ph.D. and a Master's degree in Pharmacology and Molecular Signaling from Columbia University, as well as a Bachelor's degree in Biochemistry from Brandeis University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices